Quest PharmaTech Inc.
QPT.V
TSX
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 104.40K | 87.10K | 37.30K | 235.50K | 70.70K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 179.70K | 131.20K | 84.90K | 261.10K | 115.30K |
| Operating Income | -179.70K | -131.20K | -84.90K | -261.10K | -115.30K |
| Income Before Tax | 25.40K | 525.50K | -634.80K | 10.73M | -559.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 25.40K | 525.50K | -634.80K | 10.73M | -559.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 25.40K | 525.50K | -634.80K | 10.73M | -559.70K |
| EBIT | -179.70K | -131.20K | -84.90K | -261.10K | -115.30K |
| EBITDA | -179.10K | -130.70K | -84.30K | -261.10K | -115.30K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.06 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.06 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 169.13M | 169.13M | 169.13M | 169.13M | 169.13M |
| Average Diluted Shares Outstanding | 169.13M | 169.13M | 169.13M | 169.13M | 169.13M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |